Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 4/20 | 0.44 |
| ▸ | CTSS | P25774 | 3/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.44 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.40 |
| ▸ | CTSB | P07858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10864620 | 0.89 | NOD1 (0.53) | FOLH1ITGB3ITGA2B | |
| SCHEMBL376450 | 0.89 | FOLH1 (0.53) | FOLH1CTSKCTSSITGB3ITGA2B | |
| SCHEMBL47004 | 0.89 | FOLH1 (0.53) | FOLH1CTSKCTSSITGB3ITGA2B | |
| SCHEMBL918952 | 0.89 | FOLH1 (0.53) | FOLH1CTSKCTSSITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL28376761 | 0.88 | FOLH1 (0.51) | FOLH1CTSKCTSSITGB3ITGA2B | |
| SCHEMBL30395713 | 0.88 | FOLH1 (0.51) | FOLH1CTSKCTSSITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL1711148 | 0.88 | FOLH1 (0.51) | FOLH1CTSKCTSSITGB3ITGA2B | |
| SCHEMBL6751878 | 0.88 | FOLH1 (0.51) | FOLH1CTSKCTSSITGB3ITGA2B | |
| Hydrochloric Acid SCHEMBL919653 | 0.88 | FOLH1 (0.51) | FOLH1CTSKCTSSITGB3ITGA2B | |
| SCHEMBL38662206 | 0.87 | CTSK (0.52) | FOLH1CTSKCTSSITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059231-A1 | Protease inhibitors | PROTINHI B.V. (NL) | 2025-02-20 | — | — | US | disclosed |
| CN-118459544-A | PAK sequence peptide modified diindolylmethane derivative and preparation and application thereof | 首都医科大学 | 2024-08-09 | — | — | CN | disclosed |
| CN-118459545-A | K (KAP) -RGDV modified diindolylmethane derivative and preparation and application thereof | 首都医科大学 | 2024-08-09 | — | — | CN | disclosed |
| CN-111944037-B | Synthetic method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-111944038-B | Synthetic method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-112020492-B | Method for producing amide compound | 学校法人中部大学 | 2023-05-05 | — | — | CN | disclosed |
| CN-115677827-A | Peptide compounds | 深圳市健元医药科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-110191892-B | Alanine-lysine-glutamic acid tripeptide derivative and application thereof | 深圳市健元医药科技有限公司 | 2022-04-26 | — | — | CN | disclosed |
| EP-1166781-A1 | PROTEASOME INHIBITORS | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059231-A1 | Protease inhibitors | PREP, DNPEP, TMPRSS15 | FOLH1 327/4885CTSK 165/4885CTSS 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.